Maulhardt H - Search Results

1

Phase 1/2 Trial Results of a Large Surface Area Microparticle Docetaxel for the Treatment of High-Risk Nonmuscle-Invasive Bladder Cancer.

Kates M, Mansour AM, Lamm DL, Shore N, Maulhardt H, Wendt A, Verco J, Marin A, Dewnani K, Verco S, diZerega GS. Kates M, et al. Among authors: maulhardt h. J Urol. 2022 Oct;208(4):821-829. doi: 10.1097/JU.0000000000002778. Epub 2022 May 16. J Urol. 2022. PMID: 35574612 Clinical Trial.

2

Angiotensin 1 - 7 stimulation of platelet recovery.

Rodgers KE, Peterson KJ, Maulhardt HA, diZerega GS. Rodgers KE, et al. Expert Opin Investig Drugs. 2014 Apr;23(4):551-9. doi: 10.1517/13543784.2014.891015. Epub 2014 Feb 20. Expert Opin Investig Drugs. 2014. PMID: 24555825 Review.

3

A phase I study of intraperitoneal nanoparticulate paclitaxel (Nanotax®) in patients with peritoneal malignancies.

Williamson SK, Johnson GA, Maulhardt HA, Moore KM, McMeekin DS, Schulz TK, Reed GA, Roby KF, Mackay CB, Smith HJ, Weir SJ, Wick JA, Markman M, diZerega GS, Baltezor MJ, Espinosa J, Decedue CJ. Williamson SK, et al. Cancer Chemother Pharmacol. 2015 May;75(5):1075-87. doi: 10.1007/s00280-015-2737-4. Epub 2015 Apr 23. Cancer Chemother Pharmacol. 2015. PMID: 25898813 Free PMC article. Clinical Trial.

4

Development of a guinea pig cutaneous radiation injury model using low penetrating X-rays.

Rodgers KE, Tan A, Kim L, Espinoza T, Meeks C, Johnston W, Maulhardt H, Donald M, Hill C, diZerega GS. Rodgers KE, et al. Among authors: maulhardt h. Int J Radiat Biol. 2016 Aug;92(8):434-43. doi: 10.1080/09553002.2016.1186302. Epub 2016 Jun 3. Int J Radiat Biol. 2016. PMID: 27258737

5

Local Injection of Submicron Particle Docetaxel is Associated with Tumor Eradication, Reduced Systemic Toxicity and an Immunologic Response in Uro-Oncologic Xenografts.

Maulhardt HA, Hylle L, Frost MV, Tornio A, Dafoe S, Drummond L, Quinn DI, Kamat AM, diZerega GS. Maulhardt HA, et al. Cancers (Basel). 2019 Apr 24;11(4):577. doi: 10.3390/cancers11040577. Cancers (Basel). 2019. PMID: 31022918 Free PMC article.

6

Intratumoral submicron particle docetaxel inhibits syngeneic Renca renal cancer growth and increases CD4+, CD8+, and Treg levels in peripheral blood.

Maulhardt HA, Marin AM, diZerega GS. Maulhardt HA, et al. Invest New Drugs. 2020 Oct;38(5):1618-1626. doi: 10.1007/s10637-020-00922-5. Epub 2020 Mar 20. Invest New Drugs. 2020. PMID: 32198648 Free PMC article.

7

Local administration of submicron particle paclitaxel to solid carcinomas induces direct cytotoxicity and immune-mediated tumoricidal effects without local or systemic toxicity: preclinical and clinical studies.

Verco S, Maulhardt H, Baltezor M, Williams E, Iacobucci M, Wendt A, Verco J, Marin A, Campbell S, Dorman P, diZerega G. Verco S, et al. Among authors: maulhardt h. Drug Deliv Transl Res. 2021 Oct;11(5):1806-1817. doi: 10.1007/s13346-020-00868-4. Epub 2020 Nov 6. Drug Deliv Transl Res. 2021. PMID: 33159289 Free PMC article. Review.

8

Submicron particle docetaxel intratumoral injection in combination with anti-mCTLA-4 into 4T1-Luc orthotopic implants reduces primary tumor and metastatic pulmonary lesions.

Maulhardt H, Marin A, Hesseltine H, diZerega G. Maulhardt H, et al. Med Oncol. 2021 Jul 31;38(9):106. doi: 10.1007/s12032-021-01555-1. Med Oncol. 2021. PMID: 34331595 Free PMC article.

9

Local administration of large surface area microparticle docetaxel to solid carcinomas induces direct cytotoxicity and immune-mediated tumoricidal effects: preclinical and clinical studies.

Maulhardt H, Verco S, Baltezor M, Marin A, diZerega G. Maulhardt H, et al. Drug Deliv Transl Res. 2023 Feb;13(2):503-519. doi: 10.1007/s13346-022-01226-2. Epub 2022 Sep 4. Drug Deliv Transl Res. 2023. PMID: 36058988 Free PMC article. Review.

10

Response of Locally Advanced Pancreatic Cancer to Intratumoral Injection of Large Surface Area Microparticle Paclitaxel: Initial Report of Safety and Clinical Outcome.

Sharma NR, Lo SK, Hendifar A, Othman MO, Patel K, Mendoza-Ladd A, Verco S, Maulhardt HA, Verco J, Wendt A, Marin A, Schmidt CM, diZerega G. Sharma NR, et al. Among authors: maulhardt ha. Pancreas. 2023 Mar 1;52(3):e179-e187. doi: 10.1097/MPA.0000000000002236. Pancreas. 2023. PMID: 37782888 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

14 results

Search Page